E
eMagin Corp
F:EMGA
eMagin Corp
F:EMGA
Price:
1.94
EUR
Market Closed
Market Cap:
€161.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
eMagin Corp
F:EMGA
|
US |
|
YG Plus Inc
KRX:037270
|
KR |
|
Jiangsu Huahong Technology Co Ltd
SZSE:002645
|
CN |
|
Luxfer Holdings PLC
NYSE:LXFR
|
UK |
|
Hospital Mater Dei SA
BOVESPA:MATD3
|
BR |
|
W
|
Windward Ltd
LSE:WNWD
|
IL |
Balance Sheet
Balance Sheet Decomposition
eMagin Corp
eMagin Corp
Balance Sheet Decomposition is not available for
eMagin Corp
eMagin Corp
Balance Sheet
eMagin Corp
eMagin Corp
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
4
|
5
|
9
|
5
|
4
|
3
|
4
|
10
|
6
|
4
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Cash Equivalents |
4
|
5
|
9
|
5
|
4
|
3
|
4
|
8
|
6
|
4
|
|
| Short-Term Investments |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
4
|
4
|
5
|
4
|
5
|
3
|
4
|
7
|
6
|
10
|
|
| Accounts Receivables |
4
|
4
|
5
|
4
|
5
|
3
|
4
|
6
|
6
|
9
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Inventory |
3
|
5
|
4
|
7
|
9
|
9
|
9
|
8
|
8
|
9
|
|
| Other Current Assets |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
19
|
15
|
19
|
18
|
18
|
16
|
18
|
26
|
21
|
24
|
|
| PP&E Net |
9
|
9
|
9
|
9
|
9
|
9
|
12
|
21
|
31
|
49
|
|
| PP&E Gross |
9
|
9
|
9
|
9
|
9
|
9
|
12
|
21
|
31
|
49
|
|
| Accumulated Depreciation |
7
|
8
|
9
|
11
|
10
|
11
|
13
|
15
|
18
|
21
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
29
N/A
|
25
-12%
|
28
+12%
|
27
-3%
|
27
+0%
|
25
-7%
|
30
+16%
|
48
+61%
|
51
+8%
|
73
+42%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
2
|
2
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
3
|
2
|
2
|
3
|
2
|
3
|
4
|
3
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
2
|
4
|
0
|
3
|
2
|
2
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
|
| Other Current Liabilities |
1
|
1
|
1
|
1
|
2
|
2
|
1
|
6
|
2
|
0
|
|
| Total Current Liabilities |
5
|
4
|
5
|
7
|
10
|
7
|
9
|
14
|
9
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
12
|
14
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
13
|
29
|
|
| Total Liabilities |
5
N/A
|
4
-13%
|
5
+15%
|
7
+44%
|
10
+45%
|
7
-24%
|
12
+60%
|
31
+164%
|
33
+6%
|
49
+49%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
202
|
207
|
211
|
219
|
227
|
236
|
241
|
252
|
257
|
258
|
|
| Additional Paid In Capital |
226
|
228
|
235
|
240
|
245
|
255
|
259
|
269
|
276
|
283
|
|
| Treasury Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
24
N/A
|
21
-12%
|
23
+11%
|
20
-13%
|
17
-15%
|
18
+3%
|
18
-1%
|
16
-8%
|
18
+12%
|
24
+30%
|
|
| Total Liabilities & Equity |
29
N/A
|
25
-12%
|
28
+12%
|
27
-3%
|
27
+0%
|
25
-7%
|
30
+16%
|
48
+61%
|
51
+8%
|
73
+42%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
24
|
25
|
30
|
32
|
35
|
45
|
50
|
69
|
73
|
81
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
